Your B12 Levels Look Normal, Yet You're Still Experiencing Neurological Symptoms.

MTHFR encodes an enzyme called methylenetetrahydrofolate reductase, which is central to the methylation cycle. This cycle is the cell’s primary pathway for converting dietary B vitamins (B12 and folate) into their active forms. When MTHFR works normally, it efficiently converts dietary B12 into methylcobalamin, which your nervous system uses for myelin repair, neurotransmitter synthesis, and mitochondrial energy production.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces MTHFR enzyme activity by 40 to 70%. This means your cells are converting B12 into its usable form at a fraction of the rate they should be. You can have a perfect diet, high serum B12, and still be neurologically deficient because your cells cannot process the B12 into the active form they need.

If you have a MTHFR variant, symptoms emerge slowly: tingling fingers and toes, brain fog that standard cognitive testing misses, balance problems, numbness in your lips or tongue, and a persistent fatigue that worsens with stress. These are your cells sending a distress signal that they have B12 but cannot use it.

COMT encodes catechol-O-methyltransferase, an enzyme that breaks down dopamine and norepinephrine, the neurotransmitters involved in focus, motivation, mood, and stress response. This enzyme depends on methyl groups to function, and methyl groups come from the same methylation cycle that requires active B12. When B12 metabolism is impaired, COMT function becomes dysregulated, even if your COMT gene itself is normal.

If you carry the COMT Val158Met variant (found in roughly 30% of the population), your COMT enzyme works slowly, meaning dopamine and norepinephrine accumulate in your brain. Combined with B12 deficiency, this creates a specific symptom pattern: difficulty concentrating despite good sleep, anxiety or racing thoughts, sensitivity to caffeine, and a feeling that your nervous system is overstimulated.

When B12 is low and COMT is slow, your brain becomes hypersensitive to stimulation. Caffeine hits harder. Stress feels more intense. You feel wired but exhausted at the same time. Addressing the B12 deficiency often dramatically improves these COMT-related symptoms without needing to change anything else.

SOD2 encodes superoxide dismutase 2, the primary antioxidant enzyme inside mitochondria, your cells’ energy factories. Mitochondria are where B12-dependent enzymes convert amino acids and fats into ATP, the energy your nervous system runs on. When SOD2 is working well, it protects these B12-dependent reactions from oxidative damage. When SOD2 function is impaired, mitochondrial oxidative stress accumulates, damaging the very reactions B12 is trying to power.

The Val16Ala variant in SOD2, present in roughly 25% of the population, impairs mitochondrial localization of the enzyme, reducing antioxidant protection inside your mitochondria. When combined with B12 deficiency, this creates a specific consequence: your mitochondria become unable to efficiently produce energy, even when B12 is supplemented, because oxidative damage to the B12-dependent enzymatic machinery compounds the problem.

If you have an SOD2 variant and B12 deficiency, fatigue is often the dominant symptom, along with difficulty recovering from exercise, brain fog that improves briefly with rest but returns quickly, and a sensation that your body simply doesn’t have energy reserves. Addressing B12 deficiency in this context requires additional mitochondrial support.

VDR encodes the vitamin D receptor, a cellular protein that acts like a sensor for vitamin D. When vitamin D binds to VDR, it triggers a cascade of genetic changes that regulate calcium absorption, immune function, and critically, the expression of genes involved in B12 and nutrient absorption. If your VDR doesn’t sense vitamin D efficiently, your intestines don’t upregulate the transporters that absorb B12, even if vitamin D levels appear adequate.

The FokI variant in VDR is found in roughly 30 to 50% of the population depending on ancestry. The short form (ff) of this variant produces a shorter, more efficient receptor. The long form (Ff or FF) produces a longer receptor that is less efficient at activating vitamin D responsive genes. If you carry the long form, you may have normal or even high serum vitamin D but functionally deficient vitamin D signaling, which means your intestines cannot properly absorb B12 or calcium.

With a VDR variant and B12 deficiency, you experience a double hit: poor B12 absorption from the intestine, combined with impaired calcium absorption which destabilizes nerve cell membranes. Symptoms include numbness and tingling that waxes and wanes, muscle cramps, and a sensation that your nervous system misfires unpredictably.

FADS1 encodes delta-5 desaturase, an enzyme that converts plant-based omega-3 (ALA) into EPA and DHA, the long-chain omega-3 fats that form the lipid membranes of your nerve cells and myelin sheath. Myelin is the insulation around your nerves, and it is roughly 80% fat by dry weight. If you cannot efficiently convert plant omega-3 into the specific fats myelin needs, your nerve insulation becomes thin and leaky, and neurological symptoms emerge even if your B12 levels look adequate.

The rs174537 SNP in FADS1, present in roughly 30 to 40% of the population, is associated with slower delta-5 desaturase activity. This variant means your cells struggle to convert ALA into EPA and DHA. You can eat flaxseeds and walnuts daily and still have deficient EPA and DHA in your nerve cells because the conversion step is genetically slowed.

If you have a FADS1 variant combined with B12 deficiency, neurological symptoms are often more severe because B12 is trying to repair myelin that is being built from inadequate material. Your tingling persists longer. Your balance problems are more pronounced. Your brain fog is deeper. The combination creates a compounding deficit: low B12 trying to support myelin formation from insufficient fatty acid building blocks.

HFE encodes a protein that regulates hepcidin, the master hormone that controls iron absorption in your intestine. Iron is a required cofactor in multiple B12-dependent enzymes, including methionine synthase and methylmalonyl-CoA mutase, both critical for nervous system function. Without adequate iron, even high-dose B12 supplementation cannot support these enzymatic reactions. Conversely, iron overload damages the very B12-dependent enzymes you’re trying to support.

The H63D variant in HFE, found in roughly 15 to 20% of people with European ancestry, is associated with iron dysregulation and variable iron absorption. Some carriers absorb iron too readily and develop iron overload; others have impaired absorption and become iron deficient. If you have an H63D variant, your iron status is unstable, which means B12-dependent enzyme function cannot be reliably sustained regardless of B12 supplementation alone.

With an HFE variant and B12 deficiency, symptoms often include worsening fatigue (from inadequate iron for B12 enzymes), persistent brain fog despite B12 supplementation, and neurological symptoms that improve temporarily then plateau. Your B12 is stuck, unable to fully activate its enzymatic partners because iron metabolism is dysregulated.